The Korea Office of Disease Control and Prevention (KDCA) announced today that the South Korean authorities will purchase an additional 30 million doses of the COVID-19 vaccine from the US-German consortium Pfizer / BioNTech for use in 2022.
Since the mass immunization campaign in Southeast Asia began on 26 February, at least 41.39 million people (80.6% of the population) have received the vaccine, of which 39.09 million (76). 1%) have been fully vaccinated, according to KDCA data.
In the past 24 hours, 2,344 cases of SARS-CoV-2 were confirmed and another 20 patients with COVID-19 died.
The pandemic of the new coronavirus has reached this stage with 2,936 deaths out of a total of 375,464 infections in the Asian country. The mortality rate remains unchanged at 0.78%.
The number of cases has decreased compared to the previous one (2,667); however, they remain above the level of one thousand since July 7.
382 patients with COVID-19 in a serious to critical condition (+17 in 24 hours) are hospitalized.
SOURCE:
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
